SLS (SELLAS Life Sciences Group) Buyback Yield %: 0.00 (As of Jun. 27, 2026)


SLS SELLAS Life Sciences Group Inc SLS
25 GF Score
Price $12.40
! 1 Warning Sign
View Full Analysis

What is SELLAS Life Sciences Group Buyback Yield %?

SELLAS Life Sciences Group SLS +17.55% 25 Buyback Yield % is 0.00 as of Jun. 27, 2026. GuruFocus rates SLS with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 743 Biotechnology companies, SELLAS Life Sciences Group ranks worse than 134589.37% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

SELLAS Life Sciences Group's current buyback yield was 0.00%.

SELLAS Life Sciences Group Buyback Yield % Related Terms

SELLAS Life Sciences Group Buyback Yield % Historical Data

* Premium members only.

The historical data trend for SELLAS Life Sciences Group's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SELLAS Life Sciences Group Buyback Yield % Chart

SELLAS Life Sciences Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.24 -48.40 -65.25 -60.00 -3.99

SELLAS Life Sciences Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -43.44 -19.39 -11.48 -3.99 0.00

SLS vs SNDX, CAPR, AGIO: Buyback Yield % Comparison

For the Biotechnology subindustry, SELLAS Life Sciences Group's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SELLAS Life Sciences Group Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SELLAS Life Sciences Group's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where SELLAS Life Sciences Group's Buyback Yield % falls into.


SLS
25GF Score
SELLAS Life Sciences Group Inc SLS
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SELLAS Life Sciences Group Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

SELLAS Life Sciences Group's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 23.051) / 577.19831
=-3.99%

SELLAS Life Sciences Group's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.021) / 767.03859
=-0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
SELLAS Life Sciences Group (SLS) has a Buyback Yield % of 0.00 as of Jun. 27, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on SELLAS Life Sciences Group and its competitors. According to the industry distribution chart, SELLAS Life Sciences Group ranks #999999 out of 743 companies in the Biotechnology industry.
Is SELLAS Life Sciences Group's Buyback Yield % too high?
SELLAS Life Sciences Group's current Buyback Yield % is 0.00. Based on the distribution chart, SELLAS Life Sciences Group ranks #999999 out of 743 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, SELLAS Life Sciences Group has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does SELLAS Life Sciences Group's Buyback Yield % compare to SNDX and CAPR?
According to the Biotechnology industry distribution chart, SELLAS Life Sciences Group ranks #999999 out of 743 companies for Buyback Yield %. This places SELLAS Life Sciences Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on SELLAS Life Sciences Group and its competitors. SELLAS Life Sciences Group's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SELLAS Life Sciences Group stock overvalued right now?
SELLAS Life Sciences Group (SLS) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. SELLAS Life Sciences Group's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For SELLAS Life Sciences Group (SLS), the current Buyback Yield % is 0.00 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SELLAS Life Sciences Group Business Description

Other Exchanges RXK3:Germany
Address 7 Times Square, Suite 2503, New York, NY, USA, 10036
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
25GF Score

Get the complete analysis for SLS

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.40
Price